Lynch syndrome awareness day

Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone

... read more

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more

Welcome to our updated Website

Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!

... read more

LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins the InvestHorizon Accelerator, we are delighted to have been accepted to the programme! InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding. The selected deep tech companies

... read more

The 22nd of March is Lynch syndrome awareness day. The most common hereditary cancer predisposition. However, it is largely unknown, let's change that and spread the word, it may save lives! #LynchSyndrome #LynchSyndromeAwarenessDay #FightCancer #DiagMMR

In these peculiar times, we hope that everyone stays safe and healthy. Please do comply with the recommendations of your public health officials. For yourself, society and risk groups like cancer patients! #stayathome #coloncancerawareness #lynchsyndrome

#TerkkoMugshots is a very serious blog post series, where each Terkko community member will share their darkest secrets. 👀 First up, it’s Philippe Arnez from @lscancerdiag.

We know you want to read it. 🙊 Just click it!

Tonight our CSO Minttu Kansikas will be sharing the experience of taking promising research to the market. Join the panel discussion and networking event by @Helsinkithinkco #nordicmade #entrepreneurship #lscancerdiag #diagmmr #lynchsyndrome #endcancer

Load More...